fbpx
December 16, 2020

Myeloid Leukemia Drug Disappoints in Parkinson’s Disease Myeloid Leukemia Drug Disappoints in Parkinson’s Disease

Despite showing neuroprotective effects in preclinical models of Parkinson’s disease, the tyrosine kinase inhibitor nilotinib does not appear to have a future for this indication, new […]
December 16, 2020

High Blood Pressure at Any Age Speeds Cognitive Decline High Blood Pressure at Any Age Speeds Cognitive Decline

Individuals who have hypertension at any age are more likely to experience more rapid cognitive decline compared to their counterparts with normal blood pressure, new research […]
December 16, 2020

Urgent Recall for Penumbra JET 7 Xtra Flex Reperfusion Catheters Urgent Recall for Penumbra JET 7 Xtra Flex Reperfusion Catheters

Penumbra has issued an urgent recall of all configurations of the Penumbra JET 7 Reperfusion Catheter With Xtra Flex Technology (JET 7 Xtra Flex), owing to […]
December 16, 2020

Tranexamic Acid Linked to Increased Mortality Risk in Severe TBI Tranexamic Acid Linked to Increased Mortality Risk in Severe TBI

Patients with isolated severe traumatic brain injury (TBI) often receive prophylactic tranexamic acid before hospitalization to mitigate bleeding risk, but new results suggest the agent is […]
December 15, 2020

Psychogenic Seizures Tied to Sexual Assault, Stroke Psychogenic Seizures Tied to Sexual Assault, Stroke

Individuals who have experienced sexual trauma have more than a tenfold increased risk of developing psychogenic nonepileptic seizures (PNESs) and are also more likely to suffer […]
December 15, 2020

FDA Approves Shorter Infusion Time for MS Drug Ocrelizumab FDA Approves Shorter Infusion Time for MS Drug Ocrelizumab

The US Food and Drug Administration (FDA) has approved a shorter infusion time for ocrelizumab (Ocrevus) for patients with relapsing or primary progressive multiple sclerosis (MS), […]
December 14, 2020

COVID-19 Neurologic Fallout Not Limited to the Severely Ill COVID-19 Neurologic Fallout Not Limited to the Severely Ill

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Serious neurologic complications in patients with COVID-19 are not limited to the […]
December 14, 2020

Encouraging Results for New Epilepsy Drug Encouraging Results for New Epilepsy Drug

Cenobamate (Xcopri), a new epilepsy drug, is safe and effective up to 1 year, new research shows. Post hoc analyses from an open-label study showed that […]
December 11, 2020

The ‘Wondrous Map’: Charting of the Human Genome, 20 Years Later The ‘Wondrous Map’: Charting of the Human Genome, 20 Years Later

Twenty years ago, President Bill Clinton announced completion of what was arguably one of the greatest advances of the modern era: the first draft sequence of […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0